Verena Murphy
Impact in
-
- Glioma Diagnosis and Treatment
-
- Cancer, Hypoxia, and Metabolism
Papers in
- Oncology 12
- Cancer Immunotherapy and Biomarkers 3
- Colorectal Cancer Treatments and Studies 2
-
- Cancer Genomics and Diagnostics 3
- Co-authors
- Martin Clynes (3 shared papers)Mary Heenan (1 shared paper)Laura Breen (1 shared paper)Paula Kinsella (3 shared papers)Geoffrey J. Pilkington (1 shared paper)Ian A. Cree (1 shared paper)Sharon Glaysher (1 shared paper)Louise A. Knight (1 shared paper)
- Journals
- Journal of Clinical Oncology (5 papers)Annals of Oncology (3 papers)Experimental Cell Research (2 papers)Current Cancer Drug Targets (1 paper)British Journal of Cancer (1 paper)
- Partner nations
- IrelandUnited StatesBelgium
In The Last Decade
Verena Murphy
21 papers receiving 260 citations
Peers
Comparison fields: 5 of 80
- Genetics 56
- Cancer Research 69
- Biological Psychiatry 7
- Oncology 71
- Health Informatics 3
Countries citing papers authored by Verena Murphy
This map shows the geographic impact of Verena Murphy's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Verena Murphy with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Verena Murphy more than expected).
Fields of papers citing papers by Verena Murphy
This network shows the impact of papers produced by Verena Murphy. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Verena Murphy. The network helps show where Verena Murphy may publish in the future.
Co-authors
The 25 scholars most cited alongside Verena Murphy, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 21 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2009 | 88 | |
| 2 | Investigation of the role of p53 in chemotherapy resistance of lung cancer cell lines. | 2007 | 41 |
| 3 | 2014 | 24 | |
| 4 | 2011 | 24 | |
| 5 | 2010 | 17 | |
| 6 | 2017 | 12 | |
| 7 | 2012 | 10 | |
| 8 | 2010 | 8 | |
| 9 | 2022 | 7 | |
| 10 | 2016 | 6 | |
| 11 | 2017 | 6 | |
| 12 | 2012 | 5 | |
| 13 | 2023 | 4 | |
| 14 | 2013 | 4 | |
| 15 | 2023 | 1 | |
| 16 | 2022 | 1 | |
| 17 | 2016 | 1 | |
| 18 | 2022 | 1 | |
| 19 | 2015 | 1 | |
| 20 | 2018 | 1 |
About Verena Murphy
Verena Murphy is a scholar working on Oncology, Cancer Research, Genetics, Pulmonary and Respiratory Medicine and Molecular Biology, having authored 21 papers that have together received 263 indexed citations. Recurring topics across this work include Economic and Financial Impacts of Cancer (3 papers), Cancer Immunotherapy and Biomarkers (3 papers), Cancer Genomics and Diagnostics (3 papers), Glioma Diagnosis and Treatment (3 papers), Colorectal Cancer Treatments and Studies (2 papers), Artificial Intelligence in Healthcare and Education (2 papers), Cancer Research and Treatments (2 papers) and Prostate Cancer Treatment and Research (2 papers). The work is most often cited by research in Genetics (56 citations), Cancer Research (69 citations), Biological Psychiatry (7 citations), Oncology (71 citations) and Health Informatics (3 citations). Verena Murphy has collaborated with scholars based in Ireland, United States and Belgium. Frequent co-authors include Martin Clynes, Mary Heenan, Laura Breen, Paula Kinsella, Geoffrey J. Pilkington, Ian A. Cree, Sharon Glaysher, Louise A. Knight, Annette T. Byrne and William M. Gallagher. Their work appears in journals such as Journal of Clinical Oncology, Annals of Oncology, Experimental Cell Research, Current Cancer Drug Targets and British Journal of Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.